Free shipping on all orders over $ 500

Cyclapolin 9 

Cat. No. M30051

All AbMole products are for research use only, cannot be used for human consumption.

Cyclapolin 9  Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Cyclapolin 9 is a potent, selective and ATP-competitive polo-like kinase 1 (PLK1) inhibitor with an IC50 of 500 nM. Cyclapolin 9 is inactive against other kinases.

Chemical Information
Molecular Weight 307.21
Formula C9H4F3N3O4S
CAS Number 40533-25-3
Form Solid
Solubility (25°C) DMSO 20 mg/mL (ultrasonic and warming and heat to 60°C)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Martin Hennenberg, et al. Front Physiol. Inhibition of Prostate Smooth Muscle Contraction by Inhibitors of Polo-Like Kinases

Related PLK Products
BI 2536

BI 2536 is a novel, highly selective, potent dual PLK1 and BRD4 inhibitor with IC50s of 0.83 and 25 nM, respectively.

BI 6727

BI 6727 (Volasertib) is a small highly potent Polo-like kinase inhibitor (Plk1) with an IC50 of 0 .87 nM.

GSK461364

GSK461364 is a potent and selective small molecule inhibitor of Polo-like kinase 1 (PLK1) with a Ki of 2.2 nM.

Rigosertib sodium

Rigosertib sodium is a dual non-ATP inhibitor of polo-like kinase 1 (Plk1) and phosphoinositide 3-kinase pathways (PI3K).

GW843682X

GW 843682X is a PLK inhibitor for PLK1 and PLK3 with IC50 of 2.2 nM and 9.1 nM, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: Cyclapolin 9  supplier, PLK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.